BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 905 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $228,765 | -23.0% | 6,839 | -1.6% | 0.01% | -18.2% |
| Q1 2024 | $297,128 | -11.4% | 6,952 | -19.9% | 0.01% | -15.4% |
| Q4 2023 | $335,453 | +0.7% | 8,677 | -1.7% | 0.01% | -7.1% |
| Q3 2023 | $333,018 | -17.2% | 8,824 | 0.0% | 0.01% | -12.5% |
| Q2 2023 | $402,021 | -0.3% | 8,824 | -11.3% | 0.02% | -5.9% |
| Q1 2023 | $403,329 | -26.5% | 9,944 | -7.6% | 0.02% | -29.2% |
| Q4 2022 | $548,386 | -5.6% | 10,759 | -0.2% | 0.02% | -11.1% |
| Q3 2022 | $581,000 | -16.2% | 10,785 | 0.0% | 0.03% | -10.0% |
| Q2 2022 | $693,000 | -16.2% | 10,785 | +1.1% | 0.03% | -3.2% |
| Q1 2022 | $827,000 | -17.8% | 10,667 | -9.0% | 0.03% | -11.4% |
| Q4 2021 | $1,006,000 | -0.1% | 11,717 | -7.1% | 0.04% | -5.4% |
| Q3 2021 | $1,007,000 | +6.1% | 12,617 | -0.1% | 0.04% | +2.8% |
| Q2 2021 | $949,000 | -11.1% | 12,632 | -0.2% | 0.04% | -18.2% |
| Q1 2021 | $1,067,000 | +20.3% | 12,657 | +14.5% | 0.04% | +12.8% |
| Q4 2020 | $887,000 | -12.9% | 11,057 | -12.6% | 0.04% | -20.4% |
| Q3 2020 | $1,018,000 | -8.8% | 12,657 | -2.3% | 0.05% | -14.0% |
| Q2 2020 | $1,116,000 | +6.1% | 12,957 | 0.0% | 0.06% | -10.9% |
| Q1 2020 | $1,052,000 | -9.6% | 12,957 | -6.9% | 0.06% | +14.3% |
| Q4 2019 | $1,164,000 | -4.4% | 13,917 | 0.0% | 0.06% | -11.1% |
| Q3 2019 | $1,217,000 | +6.8% | 13,917 | 0.0% | 0.06% | +5.0% |
| Q2 2019 | $1,140,000 | +0.4% | 13,917 | -0.3% | 0.06% | -1.6% |
| Q1 2019 | $1,135,000 | +23.5% | 13,957 | 0.0% | 0.06% | +8.9% |
| Q4 2018 | $919,000 | -16.7% | 13,957 | -2.4% | 0.06% | -1.8% |
| Q3 2018 | $1,103,000 | +4.5% | 14,307 | 0.0% | 0.06% | -3.4% |
| Q2 2018 | $1,056,000 | +12.7% | 14,307 | -0.7% | 0.06% | +11.3% |
| Q1 2018 | $937,000 | -0.7% | 14,407 | -1.4% | 0.05% | +3.9% |
| Q4 2017 | $944,000 | +1.9% | 14,607 | -1.0% | 0.05% | -8.9% |
| Q3 2017 | $926,000 | +0.9% | 14,757 | -2.6% | 0.06% | -1.8% |
| Q2 2017 | $918,000 | +16.5% | 15,157 | -0.3% | 0.06% | +14.0% |
| Q1 2017 | $788,000 | +17.4% | 15,204 | +0.4% | 0.05% | +11.1% |
| Q4 2016 | $671,000 | -6.9% | 15,137 | 0.0% | 0.04% | -8.2% |
| Q3 2016 | $721,000 | +5.4% | 15,137 | 0.0% | 0.05% | +4.3% |
| Q2 2016 | $684,000 | +10.0% | 15,137 | 0.0% | 0.05% | +11.9% |
| Q1 2016 | $622,000 | +7.8% | 15,137 | 0.0% | 0.04% | +7.7% |
| Q4 2015 | $577,000 | +17.5% | 15,137 | +1.4% | 0.04% | +11.4% |
| Q3 2015 | $491,000 | -53.0% | 14,932 | 0.0% | 0.04% | -50.0% |
| Q2 2015 | $1,044,000 | +2.1% | 14,932 | 0.0% | 0.07% | +4.5% |
| Q1 2015 | $1,023,000 | -6.5% | 14,932 | 0.0% | 0.07% | -6.9% |
| Q4 2014 | $1,094,000 | +2.1% | 14,932 | 0.0% | 0.07% | -1.4% |
| Q3 2014 | $1,072,000 | -0.7% | 14,932 | 0.0% | 0.07% | 0.0% |
| Q2 2014 | $1,080,000 | -5.5% | 14,932 | -3.9% | 0.07% | -8.8% |
| Q1 2014 | $1,143,000 | +4.8% | 15,532 | -1.0% | 0.08% | +1.3% |
| Q4 2013 | $1,091,000 | +6.2% | 15,682 | +0.3% | 0.08% | -3.7% |
| Q3 2013 | $1,027,000 | -53.7% | 15,635 | -50.0% | 0.08% | -12.8% |
| Q2 2013 | $2,219,000 | – | 31,270 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 53,850,000 | $2,054,378,000 | 20.84% |
| Smithwood Advisers, L.P. | 1,000,000 | $38,150,000 | 10.54% |
| SECTOR GAMMA AS | 937,600 | $35,769,000 | 9.19% |
| Smithwood Advisers, L.P. | 500,000 | $19,075,000 | 5.27% |
| Veritas Asset Management LLP | 10,592,749 | $404,113,000 | 5.07% |
| York Capital Management Global Advisors, LLC | 7,887,822 | $300,921,000 | 4.47% |
| Iguana Healthcare Management, LLC | 325,000 | $12,399,000 | 4.08% |
| Osher Van de Voorde Investment Management | 174,160 | $6,644,000 | 3.82% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $7,630,000 | 3.22% |
| Governors Lane LP | 600,000 | $22,890,000 | 3.22% |